Gene: TLE3
Official Full Name: TLE family member 3, transcriptional corepressorprovided by HGNC
Gene Summary: This gene encodes a transcriptional co-repressor protein that belongs to the transducin-like enhancer family of proteins. The members of this family function in the Notch signaling pathway that regulates determination of cell fate during development. Expression of this gene has been associated with a favorable outcome to chemotherapy with taxanes for ovarian carcinoma. Alternate splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Sep 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11643 | TLE3 Knockout cell line (HeLa) | Human | TLE3 | 1:3~1:6 | Negative | Online Inquiry |
KO11644 | TLE3 Knockout cell line (HCT 116) | Human | TLE3 | 1:2~1:4 | Negative | Online Inquiry |
KO11645 | TLE3 Knockout cell line (HEK293) | Human | TLE3 | 1:3~1:6 | Negative | Online Inquiry |
KO11646 | TLE3 Knockout cell line (A549) | Human | TLE3 | 1:3~1:4 | Negative | Online Inquiry |
TLE3 Gene Knockout Cell Lines are a pioneering biological tool engineered to facilitate the study of TLE3, a member of the Groucho family of transcriptional co-repressors. These cell lines are designed using CRISPR/Cas9 technology, ensuring precise and reproducible gene knockout for the TLE3 gene, allowing researchers to dissect its functional role in various biological processes. By removing the TLE3 gene, investigators can observe the resultant changes in cellular behavior, gene expression profiles, and signaling pathways, thereby elucidating the gene’s contribution to cellular mechanisms like proliferation, differentiation, and tumorigenesis.
The primary mechanism by which TLE3 Gene Knockout Cell Lines function is through the complete disruption of TLE3's expression, which in turn influences numerous downstream targets and networks involved in cellular regulation. This knockout leads to valuable insights into TLE3's role in health and disease contexts, particularly in oncological research where the TLE3 gene is implicated in cancer progression and resistance to treatments.
The scientific importance of these cell lines extends widely into research and clinical applications, providing essential models for understanding tumor dynamics, gene regulation, and therapeutic strategies. TLE3 Gene Knockout Cell Lines serve as a robust tool for drug discovery and the development of targeted therapies, particularly in cancers associated with aberrant TLE3 signaling.
Compared to alternative models, TLE3 Gene Knockout Cell Lines offer distinct advantages, including unparalleled specificity in knockdown efficiency and a streamlined workflow for genetic manipulation. These aspects reduce experimental variability and enhance reproducibility, making them invaluable for researchers seeking reliable and accurate results.
For researchers and clinicians focused on genomics and cancer biology, TLE3 Gene Knockout Cell Lines represent a critical resource that empowers profound biological insights and accelerates research advancements. By investing in this cutting-edge product, users gain access to high-quality experimental models backed by our company's commitment to excellence in genetic engineering and cellular biology, ensuring that researchers are equipped with the best tools to achieve groundbreaking insights.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.